Study Georgian Med News 2024

RATIONALE AND ANALYSIS OF THE EFFECT OF HBOT THERAPY IN THE RECOVERY OF LONG COVID PATIENTS

Gonevski M — Georgian Med News, 2024

View Original on PubMed PMID 39089276

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

A physician in Georgia collected data on 63 Long COVID patients (ages 22–74) treated with HBOT at 2.4 ATA for 10 or 15 sessions and tracked their symptoms before and after treatment.

What They Found

Approximately 90% of all patients showed improvement compared to their starting condition, including improvements in cognitive function, fatigue, shortness of breath, and psychological well-being. No adverse effects were reported. Follow-up at three months showed that the benefits were maintained.

Canadian Relevance

No direct Canadian connection identified. Long COVID is not currently an OHIP-covered indication for HBOT in Ontario.

Study Limitations

This study had no control group, meaning improvements could reflect natural Long COVID recovery over time rather than a treatment effect, and the author's affiliation with treating patients creates potential bias.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type	Study
Category	Neurological
Source	Pubmed
PubMed ID	39089276
Year Published	2024
Journal	Georgian Med News
MeSH Terms	Humans; COVID-19; Male; Middle Aged; Hyperbaric Oxygenation; Female; Adult; Aged; Post-Acute COVID-19 Syndrome; SARS-CoV-2; Fatigue; Young Adult; Treatment Outcome; Dyspnea

Related Research

PLoS ONE | 2013 RCT

Hyperbaric oxygen induces late neuroplasticity in post stroke patients--randomized, prospective trial.

Efrati S, Fishlev G, Bechor Y, et al.

J Neurotrauma | 2018 Systematic Review

Hyperbaric oxygen therapy in the treatment of acute severe traumatic brain injury: a systematic review

Daly S, Thorpe M, Rockswold S, et al.

J Neurotrauma | 2012 Pilot Study

A phase I study of low-pressure hyperbaric oxygen therapy for blast-induced post-concussion syndrome and PTSD

Harch PG, Andrews SR, Fogarty EF, et al.

Scientific Reports | 2022 RCT

Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial.

Hadanny A, Zilberman-Itskovich S, Catalogna M, et al.

PLoS ONE | 2013 RCT

Hyperbaric oxygen therapy can improve post concussion syndrome years after mild traumatic brain injury — randomized prospective trial

Boussi-Gross R, Golan H, Fishlev G, et al.

See all Neurological research

View on PubMed Back to Research Library

Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology